DKK3 and ovarian carcinoma: Although a previous study did not find any correlation between DKK3 loss and clinicopathological parameters of ovarian cancer [20], the results of univariate survival analysis in this study showed that DKK3 loss was a prognostic factor, along with the FIGO stage, suboptimality of debulking surgery, and chemoresistance.